Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)

China flag China · Delayed Price · Currency is CNY
18.65
0.00 (0.00%)
Apr 29, 2026, 3:04 PM CST
-9.42%
Market Cap 8.66B
Revenue (ttm) 1.87B
Net Income (ttm) -167.76M
Shares Out 464.53M
EPS (ttm) -0.35
PE Ratio n/a
Forward PE 20.35
Dividend 0.22 (1.18%)
Ex-Dividend Date May 20, 2025
Volume 4,970,727
Average Volume 5,429,659
Open 18.31
Previous Close 18.65
Day's Range 18.31 - 18.78
52-Week Range 17.33 - 26.29
Beta 1.06
RSI 53.73
Earnings Date Apr 23, 2026

About SHE:300482

Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, market, sale, and service of vitro diagnostic products in China. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious disease, fertility, tumor marker, and sexually transmitted diseases; immunofluorescence platform for detecting cardiac, thyroid, rheumatoid arthritis, sex hormone, anemia, gastroenterology, hypertension, thrombus, tumor, inflammation, diabetes, allergy, respiratory infection, kidney... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1992
Employees 3,197
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300482
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.